All updates
All updates
today 289The Lancet精选评分7171 中文产业新闻Chinese source评分5959 Nature新研究揭示mRNA剪接完成后剪接体脱离的最后一步分子机制
中文产业新闻Chinese source评分4040 Nature Biotechnology | 眼睛可能比血压更早暴露风险？视网膜AI揭示子痫前期早期血管异常
中文产业新闻Chinese source评分6868 梯瓦每月一次皮下注射奥氮平 WELTRUZA 获 FDA 批准用于成人精神分裂症
中文产业新闻精选Chinese source评分6969 晖致 16.5 亿美元收购 Pacira 加码非阿片类疼痛业务
中文产业新闻精选Chinese source评分6363 Argenx 终止 efgartigimod 干燥综合征 III 期 UNITY 试验，主要终点未达
监管与产业动态评分4949 JAK-inhibitor treatment induces rapid yet incomplete immune reconstitution in STAT1 gain-of-function
监管与产业动态评分2828 cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review)
监管与产业动态评分2929 Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)
监管与产业动态评分1717 Does a bone tumor always mean cancer?
监管与产业动态精选评分8585 Program helping patients self-regulate strong-opioid use has potential for NHS, study shows
监管与产业动态评分3434 TRex rakes in $117M IPO, while Retension reveals $45M listing - Fierce Biotech
监管与产业动态评分1616 Free lunches for clinicians bloat prescription bills: review - Fierce Pharma
监管与产业动态精选评分6969 Immune cell map uncovers how individual aging trajectories diverge
监管与产业动态评分2828 MHRA Chair Professor Anthony Harnden: Bringing our strategy to life – listening, learning, and looking ahead
监管与产业动态评分1111 How we picked the Fierce 15 - Fierce Biotech
监管与产业动态精选评分5252 Lab-grown blood vessels reveal roles of different cells in rapid-aging disease
监管与产业动态评分2222 Chutes & Ladders—Vir looks to Liu to lead late-stage push - Fierce Biotech
监管与产业动态精选评分5858 Blood cells from 80-year-old donor become stem cells with molecular age under 20
监管与产业动态评分2222 ‘We’re making a lot of progress’: How Nobel-winning optogenetics is being harnessed by biotechs - Fierce Biotech
监管与产业动态精选评分6969 Enzyme inhibitor limits scarring after heart attacks and protects heart function in mice
监管与产业动态评分5454 Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives - Fierce Pharma
监管与产业动态精选评分5454 How the benefits of vaccination extend beyond protection from infection
监管与产业动态评分3030 GSK drinks in Chai Discovery’s AI models after wet-lab validation - Fierce Biotech
监管与产业动态精选评分7979 Gut microbes help set the body's inflammatory response to vaccination
监管与产业动态评分2020 Quince relaunches as IRuyla, going all in on lung disease after Hail Mary merger - Fierce Pharma
监管与产业动态精选评分6565 Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment
监管与产业动态评分4040 FDA’s Rasonque review documents pressure RevMed as investors jitter over KRAS subgroup data - Fierce Pharma
监管与产业动态精选评分5454 Blood cancer study links blood formation and bone health
监管与产业动态评分2525 Ferass Abuzaina named Worldwide President of Surgery at BD - Fierce Biotech
监管与产业动态评分4646 T-cell research reveals paths to better vaccines for COVID-19 and beyond
监管与产业动态精选评分5353 GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen - Fierce Pharma
监管与产业动态评分77 How advanced AI can improve clinical trial decision-making - Fierce Pharma
监管与产业动态评分77 How AI-Powered Simulations Help Teams Plan Smarter Studies - Fierce Pharma
监管与产业动态评分88 Signal or noise? > Health Rounds: Blindness treatment based on Nobel-winning research shows promise - WTVB >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #healthcare #pharmaceutical #biotech
中文产业新闻精选Chinese source评分7272 四川大学华西医院发表Mol Psychiatry研究：DIA蛋白质组学揭示子痫前期后代星形胶质细胞BCL2下调致血脑屏障破坏
中文产业新闻Chinese source评分6464 梯瓦奥氮平长效注射液WELTRUZA获FDA批准，为全球首个每月一次长效精神分裂症药物
中文产业新闻精选Chinese source评分6666 艾力斯回应伏美替尼FURVENT三期失败：称化疗组评估差异大、专家认可疗效预期
中文产业新闻精选Chinese source评分8080 众生睿创RAY1225三期双周给药达主要终点，9mg组安慰剂校正减重20.46%
中文产业新闻精选Chinese source评分8080 行业研究｜罗氏 enicepatide 24mg 48 周减重与降糖数据对标替尔泊肽